GB1479268A
(en)
|
1973-07-05 |
1977-07-13 |
Beecham Group Ltd |
Pharmaceutical compositions
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
CH596313A5
(de)
|
1975-05-30 |
1978-03-15 |
Battelle Memorial Institute |
|
US4385260A
(en)
|
1975-09-09 |
1983-05-24 |
Beckman Instruments, Inc. |
Bargraph display
|
US4414147A
(en)
|
1981-04-17 |
1983-11-08 |
Massachusetts Institute Of Technology |
Methods of decreasing the hydrophobicity of fibroblast and other interferons
|
JPS57206622A
(en)
|
1981-06-10 |
1982-12-18 |
Ajinomoto Co Inc |
Blood substitute
|
US4438253A
(en)
*
|
1982-11-12 |
1984-03-20 |
American Cyanamid Company |
Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
US4565653A
(en)
|
1984-03-30 |
1986-01-21 |
Pfizer Inc. |
Acyltripeptide immunostimulants
|
US4879236A
(en)
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
JPS6238172A
(ja)
|
1985-08-12 |
1987-02-19 |
株式会社 高研 |
抗血栓性医用材料の製造方法
|
US4925796A
(en)
|
1986-03-07 |
1990-05-15 |
Massachusetts Institute Of Technology |
Method for enhancing glycoprotein stability
|
JPS63502716A
(ja)
|
1986-03-07 |
1988-10-13 |
マサチューセッツ・インステチュート・オブ・テクノロジー |
糖タンパク安定性の強化方法
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
IL82834A
(en)
*
|
1987-06-09 |
1990-11-05 |
Yissum Res Dev Co |
Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
|
US4847325A
(en)
|
1988-01-20 |
1989-07-11 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
US5153265A
(en)
|
1988-01-20 |
1992-10-06 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
GB8810808D0
(en)
|
1988-05-06 |
1988-06-08 |
Wellcome Found |
Vectors
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US5104651A
(en)
*
|
1988-12-16 |
1992-04-14 |
Amgen Inc. |
Stabilized hydrophobic protein formulations of g-csf
|
US6166183A
(en)
|
1992-11-30 |
2000-12-26 |
Kirin-Amgen, Inc. |
Chemically-modified G-CSF
|
EP0401384B1
(de)
|
1988-12-22 |
1996-03-13 |
Kirin-Amgen, Inc. |
Chemisch modifizierte granulocytenkolonie erregender faktor
|
EP0454730A1
(de)
*
|
1989-01-19 |
1991-11-06 |
The Upjohn Company |
Somatotropinanaloga
|
JP3207416B2
(ja)
*
|
1989-01-31 |
2001-09-10 |
ファルマシア・アンド・アップジョン・カンパニー |
ソマトトロピン・アナログ類
|
US5194376A
(en)
|
1989-02-28 |
1993-03-16 |
University Of Ottawa |
Baculovirus expression system capable of producing foreign gene proteins at high levels
|
US5122614A
(en)
*
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
DE69034200T2
(de)
|
1989-04-19 |
2006-05-24 |
Enzon, Inc. |
Verfahren zum Herstellen von modifizierten Polypeptiden die eine Polypeptid und ein Polyalkylenoxid enthalten
|
US5324844A
(en)
*
|
1989-04-19 |
1994-06-28 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
US5342940A
(en)
|
1989-05-27 |
1994-08-30 |
Sumitomo Pharmaceuticals Company, Limited |
Polyethylene glycol derivatives, process for preparing the same
|
US5977307A
(en)
|
1989-09-07 |
1999-11-02 |
Alkermes, Inc. |
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
|
US5182107A
(en)
|
1989-09-07 |
1993-01-26 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
US5672683A
(en)
|
1989-09-07 |
1997-09-30 |
Alkermes, Inc. |
Transferrin neuropharmaceutical agent fusion protein
|
US5154924A
(en)
|
1989-09-07 |
1992-10-13 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
US5527527A
(en)
|
1989-09-07 |
1996-06-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
US5032519A
(en)
*
|
1989-10-24 |
1991-07-16 |
The Regents Of The Univ. Of California |
Method for producing secretable glycosyltransferases and other Golgi processing enzymes
|
US5312808A
(en)
|
1989-11-22 |
1994-05-17 |
Enzon, Inc. |
Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
|
US5595900A
(en)
*
|
1990-02-14 |
1997-01-21 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
US5324663A
(en)
*
|
1990-02-14 |
1994-06-28 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
DE4009630C2
(de)
|
1990-03-26 |
1995-09-28 |
Reinhard Prof Dr Dr Brossmer |
CMP-aktivierte fluoreszierende Sialinsäuren sowie Verfahren zu ihrer Herstellung
|
US5583042A
(en)
|
1990-04-16 |
1996-12-10 |
Neose Pharmaceuticals, Inc. |
Apparatus for the synthesis of saccharide compositions
|
US5951972A
(en)
*
|
1990-05-04 |
1999-09-14 |
American Cyanamid Company |
Stabilization of somatotropins and other proteins by modification of cysteine residues
|
US5219564A
(en)
*
|
1990-07-06 |
1993-06-15 |
Enzon, Inc. |
Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
|
CU22302A1
(es)
|
1990-09-07 |
1995-01-31 |
Cigb |
Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales
|
US5410016A
(en)
*
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5529914A
(en)
*
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
US5506107A
(en)
*
|
1991-05-10 |
1996-04-09 |
Genentech, Inc. |
Selecting ligand agonists and antagonists
|
US5374655A
(en)
|
1991-06-10 |
1994-12-20 |
Alberta Research Council |
Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures
|
US5352670A
(en)
|
1991-06-10 |
1994-10-04 |
Alberta Research Council |
Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
|
KR950014915B1
(ko)
|
1991-06-19 |
1995-12-18 |
주식회사녹십자 |
탈시알로당단백-포함화합물
|
US5281698A
(en)
*
|
1991-07-23 |
1994-01-25 |
Cetus Oncology Corporation |
Preparation of an activated polymer ester for protein conjugation
|
IT1260468B
(it)
|
1992-01-29 |
1996-04-09 |
|
Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
|
US5962294A
(en)
|
1992-03-09 |
1999-10-05 |
The Regents Of The University Of California |
Compositions and methods for the identification and synthesis of sialyltransferases
|
US5858751A
(en)
|
1992-03-09 |
1999-01-12 |
The Regents Of The University Of California |
Compositions and methods for producing sialyltransferases
|
US6037452A
(en)
|
1992-04-10 |
2000-03-14 |
Alpha Therapeutic Corporation |
Poly(alkylene oxide)-Factor VIII or Factor IX conjugate
|
US5614184A
(en)
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
WO1994004193A1
(en)
|
1992-08-21 |
1994-03-03 |
Enzon, Inc. |
Novel attachment of polyalkylene oxides to bio-effecting substances
|
JP3979678B2
(ja)
|
1992-08-24 |
2007-09-19 |
サントリー株式会社 |
新規糖転移酵素及びそれをコードする遺伝子並びに該酵素の製造方法
|
NZ250375A
(en)
|
1992-12-09 |
1995-07-26 |
Ortho Pharma Corp |
Peg hydrazone and peg oxime linkage forming reagents and protein derivatives
|
AU6029594A
(en)
|
1993-01-15 |
1994-08-15 |
Enzon, Inc. |
Factor viii - polymeric conjugates
|
US5349001A
(en)
|
1993-01-19 |
1994-09-20 |
Enzon, Inc. |
Cyclic imide thione activated polyalkylene oxides
|
US5321095A
(en)
|
1993-02-02 |
1994-06-14 |
Enzon, Inc. |
Azlactone activated polyalkylene oxides
|
US5202413A
(en)
*
|
1993-02-16 |
1993-04-13 |
E. I. Du Pont De Nemours And Company |
Alternating (ABA)N polylactide block copolymers
|
US5374541A
(en)
|
1993-05-04 |
1994-12-20 |
The Scripps Research Institute |
Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
|
EP0726318A1
(de)
|
1993-05-14 |
1996-08-14 |
The Upjohn Company |
Akzeptorpolypeptid für N-Acetylgalaktosaminyltransferase
|
US5621039A
(en)
|
1993-06-08 |
1997-04-15 |
Hallahan; Terrence W. |
Factor IX- polymeric conjugates
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5643575A
(en)
*
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
US5443953A
(en)
|
1993-12-08 |
1995-08-22 |
Immunomedics, Inc. |
Preparation and use of immunoconjugates
|
US5369017A
(en)
|
1994-02-04 |
1994-11-29 |
The Scripps Research Institute |
Process for solid phase glycopeptide synthesis
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US5492841A
(en)
|
1994-02-18 |
1996-02-20 |
E. I. Du Pont De Nemours And Company |
Quaternary ammonium immunogenic conjugates and immunoassay reagents
|
US5432059A
(en)
|
1994-04-01 |
1995-07-11 |
Specialty Laboratories, Inc. |
Assay for glycosylation deficiency disorders
|
US5646113A
(en)
|
1994-04-07 |
1997-07-08 |
Genentech, Inc. |
Treatment of partial growth hormone insensitivity syndrome
|
US5629384A
(en)
*
|
1994-05-17 |
1997-05-13 |
Consiglio Nazionale Delle Ricerche |
Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
|
US5545553A
(en)
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
US5834251A
(en)
|
1994-12-30 |
1998-11-10 |
Alko Group Ltd. |
Methods of modifying carbohydrate moieties
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
US6030815A
(en)
|
1995-04-11 |
2000-02-29 |
Neose Technologies, Inc. |
Enzymatic synthesis of oligosaccharides
|
US5728554A
(en)
|
1995-04-11 |
1998-03-17 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
US5876980A
(en)
|
1995-04-11 |
1999-03-02 |
Cytel Corporation |
Enzymatic synthesis of oligosaccharides
|
US5922577A
(en)
|
1995-04-11 |
1999-07-13 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
US6015555A
(en)
|
1995-05-19 |
2000-01-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
US5824864A
(en)
|
1995-05-25 |
1998-10-20 |
Pioneer Hi-Bred International, Inc. |
Maize gene and protein for insect control
|
US6127153A
(en)
|
1995-06-07 |
2000-10-03 |
Neose Technologies, Inc. |
Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase
|
US5858752A
(en)
*
|
1995-06-07 |
1999-01-12 |
The General Hospital Corporation |
Fucosyltransferase genes and uses thereof
|
US5672662A
(en)
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
US5770420A
(en)
*
|
1995-09-08 |
1998-06-23 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
CA2230492C
(en)
|
1995-09-21 |
2009-05-26 |
Genentech, Inc. |
Human growth hormone variants
|
US5716812A
(en)
|
1995-12-12 |
1998-02-10 |
The University Of British Columbia |
Methods and compositions for synthesis of oligosaccharides, and the products formed thereby
|
EP0888377B1
(de)
*
|
1996-03-08 |
2007-12-12 |
The Regents Of The University Of Michigan |
MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
US6454946B1
(en)
|
1996-10-10 |
2002-09-24 |
Neose Technologies, Inc. |
Carbohydrate purification using ultrafiltration, reverse osmosis and nanofiltration
|
IL130823A
(en)
|
1996-10-15 |
2005-12-18 |
Elan Pharm Inc |
Peptide-lipid conjugates, liposomes drug delivery
|
JP2001503274A
(ja)
|
1996-11-08 |
2001-03-13 |
サイテル コーポレイション |
改良された発現ベクター
|
JP2001507215A
(ja)
|
1997-01-16 |
2001-06-05 |
サイテル コーポレイション |
組換え糖タンパク質のインビトロでの実用的なシアリル化
|
US5945314A
(en)
|
1997-03-31 |
1999-08-31 |
Abbott Laboratories |
Process for synthesizing oligosaccharides
|
WO1998049198A1
(en)
*
|
1997-04-30 |
1998-11-05 |
Enzon, Inc. |
Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
|
US6183738B1
(en)
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
US6399337B1
(en)
*
|
1997-06-06 |
2002-06-04 |
The Governors Of The University Of Alberta |
α1,3-fucosyltransferase
|
WO1999000150A2
(en)
|
1997-06-27 |
1999-01-07 |
Regents Of The University Of California |
Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor
|
US20030027257A1
(en)
*
|
1997-08-21 |
2003-02-06 |
University Technologies International, Inc. |
Sequences for improving the efficiency of secretion of non-secreted protein from mammalian and insect cells
|
WO1999022764A1
(en)
|
1997-10-31 |
1999-05-14 |
Genentech, Inc. |
Methods and compositions comprising glycoprotein glycoforms
|
AU744303B2
(en)
|
1997-12-01 |
2002-02-21 |
Neose Technologies, Inc. |
Enzymatic synthesis of gangliosides
|
EP0924298A1
(de)
|
1997-12-18 |
1999-06-23 |
Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) |
Proteinexpression in Baculovirus-vektor Expressionsystemen
|
DE69913316T2
(de)
|
1998-01-07 |
2004-11-18 |
Debio Recherche Pharmaceutique S.A. |
Abbaubare, heterobifunktionelle polyethylenglykolacrylate, sowie damit herstellbare gele und konjugate
|
EP1061954B1
(de)
|
1998-03-12 |
2004-06-09 |
Nektar Therapeutics Al, Corporation |
Polyethylenglycolderivate mit benachbarten reaktiven gruppen
|
WO1999048515A1
(en)
*
|
1998-03-25 |
1999-09-30 |
Sloan-Kettering Institute For Cancer Research |
Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
|
US20030166525A1
(en)
|
1998-07-23 |
2003-09-04 |
Hoffmann James Arthur |
FSH Formulation
|
US7304150B1
(en)
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
JP2002531067A
(ja)
*
|
1998-10-30 |
2002-09-24 |
ノボザイムス アクティーゼルスカブ |
低下したアレルゲン性を有するグリコシル化タンパク質
|
DE19852729A1
(de)
|
1998-11-16 |
2000-05-18 |
Werner Reutter |
Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
|
US6465220B1
(en)
|
1998-12-21 |
2002-10-15 |
Glycozym Aps |
Glycosylation using GalNac-T4 transferase
|
US6949372B2
(en)
|
1999-03-02 |
2005-09-27 |
The Johns Hopkins University |
Engineering intracellular sialylation pathways
|
US6261805B1
(en)
|
1999-07-15 |
2001-07-17 |
Boyce Thompson Institute For Plant Research, Inc. |
Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
|
US6537785B1
(en)
|
1999-09-14 |
2003-03-25 |
Genzyme Glycobiology Research Institute, Inc. |
Methods of treating lysosomal storage diseases
|
US6716626B1
(en)
*
|
1999-11-18 |
2004-04-06 |
Chiron Corporation |
Human FGF-21 nucleic acids
|
US6348558B1
(en)
*
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
EP2070968A3
(de)
*
|
1999-12-22 |
2013-07-24 |
Nektar Therapeutics |
Verfahren zur Herstellung von 1-Benzotriazolylcarbonatestern von Poly(ethylenglykol)
|
WO2001049830A2
(en)
|
1999-12-30 |
2001-07-12 |
Maxygen Aps |
Improved lysosomal enzymes and lysosomal enzyme activators
|
US6555660B2
(en)
*
|
2000-01-10 |
2003-04-29 |
Maxygen Holdings Ltd. |
G-CSF conjugates
|
PL204285B1
(pl)
|
2000-02-11 |
2009-12-31 |
Bayer Healthcare Llc |
Koniugat polipeptydowy, polipeptyd, sekwencja nukleotydowa, wektor ekspresyjny, komórka gospodarz, sposób wytwarzania koniugatu polipeptydowego, środek farmaceutyczny i zastosowanie koniugatu polipeptydowego
|
AU2001232337A1
(en)
|
2000-02-18 |
2001-08-27 |
Kanagawa Academy Of Science And Technology |
Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance
|
ATE329925T1
(de)
*
|
2000-03-16 |
2006-07-15 |
Univ California |
Chemoselektive anknüpfung durch verwendung eines phosphins
|
US6586398B1
(en)
*
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
US7338932B2
(en)
|
2000-05-11 |
2008-03-04 |
Glycozym Aps |
Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
|
JP2004528001A
(ja)
|
2000-05-12 |
2004-09-16 |
ネオーズ テクノロジーズ, インコーポレイテッド |
インビトロにおけるフコシル化組換えグリコペプチド
|
NZ522030A
(en)
|
2000-05-15 |
2004-11-26 |
F |
Erythropoietin composition with a multiple charged inorganic anion i.e. a sulfate a citrate or a phosphate to stabilize the composition
|
ES2330330T3
(es)
|
2000-06-28 |
2009-12-09 |
Glycofi, Inc. |
Procedimiento de produccion de glucoproteinas modificadas.
|
WO2002002597A2
(en)
|
2000-06-30 |
2002-01-10 |
Maxygen Aps |
Peptide extended glycosylated polypeptides
|
US6423826B1
(en)
|
2000-06-30 |
2002-07-23 |
Regents Of The University Of Minnesota |
High molecular weight derivatives of vitamin K-dependent polypeptides
|
WO2002013843A2
(en)
|
2000-08-17 |
2002-02-21 |
University Of British Columbia |
Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
|
MXPA03005406A
(es)
|
2000-12-20 |
2003-09-25 |
Hoffmann La Roche |
Conjugados de eritropoyetina.
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US6531121B2
(en)
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
CA2469846A1
(en)
|
2001-02-27 |
2002-09-26 |
Maxygen Aps |
New interferon beta-like molecules
|
US7235638B2
(en)
*
|
2001-03-22 |
2007-06-26 |
Novo Nordisk Healthcare A/G |
Coagulation factor VII derivatives
|
CA2445494A1
(en)
|
2001-05-11 |
2002-11-21 |
Aradigm Corporation |
Optimization of the molecular properties and formulation of proteins delivered by inhalation
|
US7271150B2
(en)
|
2001-05-14 |
2007-09-18 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Modified growth hormone
|
KR100453877B1
(ko)
*
|
2001-07-26 |
2004-10-20 |
메덱스젠 주식회사 |
연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 TNFR/Fc 융합 단백질, 상기 단백질을 코딩하는 DNA, 상기 DNA를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
|
AU2002326805B2
(en)
|
2001-08-29 |
2009-01-22 |
Seneb Biosciences, Inc. |
Novel synthetic ganglioside derivatives and compositions thereof
|
US7265085B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
US7265084B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
ES2606840T3
(es)
|
2001-10-10 |
2017-03-28 |
Ratiopharm Gmbh |
Remodelación y glicoconjugación de factor estimulante de colonias de granulocitos (G-CSF)
|
US7173003B2
(en)
*
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7157277B2
(en)
*
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US8008252B2
(en)
*
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
US7696163B2
(en)
*
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7439043B2
(en)
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
US7179617B2
(en)
*
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
US7226903B2
(en)
*
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
US7399613B2
(en)
*
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
US7125843B2
(en)
*
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
US7297511B2
(en)
*
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
AU2002351197A1
(en)
*
|
2001-11-28 |
2003-06-10 |
Neose Technologies, Inc. |
Glycopeptide remodeling using amidases
|
US7473680B2
(en)
*
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
US20060035224A1
(en)
*
|
2002-03-21 |
2006-02-16 |
Johansen Jack T |
Purification methods for oligonucleotides and their analogs
|
MXPA04012496A
(es)
|
2002-06-21 |
2005-09-12 |
Novo Nordisk Healthcare Ag |
Glicoformos del factor vii pegilados.
|
DE10232916B4
(de)
|
2002-07-19 |
2008-08-07 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vorrichtung und Verfahren zum Charakterisieren eines Informationssignals
|
JP2005533525A
(ja)
|
2002-07-23 |
2005-11-10 |
ニオズ テクノロジーズ インコーポレイテッド |
細菌グリコシルトランスフェラーゼを用いたオリゴ糖、糖脂質、及び糖タンパク質の合成
|
CA2497777A1
(en)
|
2002-09-05 |
2004-03-18 |
The General Hospital Corporation |
Modified asialo-interferons and uses thereof
|
JP2006501820A
(ja)
|
2002-09-06 |
2006-01-19 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
修飾glp−1受容体アゴニストおよびそれらの薬理学的使用法
|
ATE365794T1
(de)
*
|
2002-11-08 |
2007-07-15 |
Glycozym Aps |
Verfahren zur identifizierung von die funktionen von polypeptid-galnac-transferasen modulierenden agentien, solche agentien umfassende pharmazeutische zusammensetzungen und verwendung solcher agentien zur herstellung von arzneimitteln
|
JP4412461B2
(ja)
|
2002-11-20 |
2010-02-10 |
日油株式会社 |
修飾された生体関連物質、その製造方法および中間体
|
US20050064540A1
(en)
*
|
2002-11-27 |
2005-03-24 |
Defrees Shawn Ph.D |
Glycoprotein remodeling using endoglycanases
|
EP1424344A1
(de)
|
2002-11-29 |
2004-06-02 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
Modifizierte cDNA des Factors VIII und Derivate davon
|
DK1428878T3
(da)
|
2002-12-13 |
2008-12-08 |
Bioceuticals Arzneimittel Ag |
Fremgangsmåde til produktion og oprensning af erythropoietin
|
US7803777B2
(en)
*
|
2003-03-14 |
2010-09-28 |
Biogenerix Ag |
Branched water-soluble polymers and their conjugates
|
JP2006520840A
(ja)
|
2003-03-18 |
2006-09-14 |
ネオス テクノロジーズ インコーポレイテッド |
水溶性高分子の活性化形
|
EP2055189A1
(de)
|
2003-04-09 |
2009-05-06 |
Neose Technologies, Inc. |
Glycopegylierungsverfahren und durch die Verfahren hergestellte Proteine/Peptide
|
WO2004091499A2
(en)
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
US7718363B2
(en)
|
2003-04-25 |
2010-05-18 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
|
US7932364B2
(en)
|
2003-05-09 |
2011-04-26 |
Novo Nordisk A/S |
Compositions and methods for the preparation of human growth hormone glycosylation mutants
|
US9005625B2
(en)
*
|
2003-07-25 |
2015-04-14 |
Novo Nordisk A/S |
Antibody toxin conjugates
|
US20060198819A1
(en)
|
2003-08-08 |
2006-09-07 |
Novo Nordisk Healthcare A/G |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
BRPI0409650A
(pt)
|
2003-09-09 |
2006-04-25 |
Warren Pharmaceuticals Inc |
métodos para regular o nìvel hematócrito e humanos, produtos de eritropoietina artificial, métodos para preparar um produto de eritropoietina e pra tratar anemia em pacientes em risco de dano no tecido, e, composição farmacêutica
|
US7524813B2
(en)
*
|
2003-10-10 |
2009-04-28 |
Novo Nordisk Health Care Ag |
Selectively conjugated peptides and methods of making the same
|
KR20060120141A
(ko)
|
2003-11-24 |
2006-11-24 |
네오스 테크놀로지스, 인크. |
글리코페질화 에리트로포이에틴
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
WO2005072371A2
(en)
|
2004-01-26 |
2005-08-11 |
Neose Technologies, Inc. |
Branched polymeric sugars and nucleotides thereof
|
WO2005056760A2
(en)
|
2003-12-03 |
2005-06-23 |
Neose Technologies, Inc. |
Glycopegylated follicle stimulating hormone
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
US20080318850A1
(en)
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
CA2549409C
(en)
|
2003-12-03 |
2013-10-29 |
Neose Technologies, Inc. |
Glycopegylated granulocyte colony stimulating factor
|
KR101439880B1
(ko)
*
|
2004-01-08 |
2014-09-12 |
라티오팜 게엠베하 |
펩티드의 오-결합형 글리코실화
|
WO2005067601A2
(en)
|
2004-01-09 |
2005-07-28 |
Neose Technologies, Inc. |
Vectors for recombinant protein expression in e.coli
|
US20070105770A1
(en)
|
2004-01-21 |
2007-05-10 |
Novo Nordisk A/S |
Transglutaminase mediated conjugation of peptides
|
EP1735340A2
(de)
|
2004-03-17 |
2006-12-27 |
Eli Lilly And Company |
Glykolgebundene fgf-21-verbindungen
|
DE602005019038D1
(de)
|
2004-05-04 |
2010-03-11 |
Novo Nordisk Healthcare Ag |
O-verknüpfte glykoformen von faktor vii und verfahren zu deren herstellung
|
WO2005121332A2
(en)
|
2004-06-03 |
2005-12-22 |
Neose Technologies, Inc. |
Truncated st6galnaci polypeptides and nucleic acids
|
WO2005121331A2
(en)
|
2004-06-03 |
2005-12-22 |
Neose Technologies, Inc. |
Truncated galnact2 polypeptides and nucleic acids
|
US20080305990A1
(en)
|
2004-07-02 |
2008-12-11 |
The Kenneth S Warren Institute, Inc. |
Method of Producing Fully Carbamylated Erythropoietin
|
WO2006014466A2
(en)
|
2004-07-02 |
2006-02-09 |
The Kenneth S. Warren Institute, Inc. |
Novel carbamylated epo and method for its production
|
US20080300173A1
(en)
|
2004-07-13 |
2008-12-04 |
Defrees Shawn |
Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
|
WO2006020372A2
(en)
|
2004-07-23 |
2006-02-23 |
Neose Technologies, Inc. |
Enzymatic modification of glycopeptides
|
JP2008507990A
(ja)
|
2004-08-02 |
2008-03-21 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
Fviiの抱合体
|
US20060024286A1
(en)
|
2004-08-02 |
2006-02-02 |
Paul Glidden |
Variants of tRNA synthetase fragments and uses thereof
|
US8268967B2
(en)
*
|
2004-09-10 |
2012-09-18 |
Novo Nordisk A/S |
Glycopegylated interferon α
|
JP2008514215A
(ja)
*
|
2004-09-29 |
2008-05-08 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
改変タンパク質
|
DK2586456T3
(en)
|
2004-10-29 |
2016-03-21 |
Ratiopharm Gmbh |
Conversion and glycopegylation of fibroblast growth factor (FGF)
|
WO2006066258A2
(en)
*
|
2004-12-17 |
2006-06-22 |
Neose Technologies, Inc. |
Lipoconjugation of peptides
|
JP2008526864A
(ja)
|
2005-01-06 |
2008-07-24 |
ネオス テクノロジーズ インコーポレイテッド |
糖断片を用いる糖結合
|
EP1858543B1
(de)
|
2005-01-10 |
2013-11-27 |
BioGeneriX AG |
Glycopegylierten Granulocyten-Kolonie-stimulierender Faktor
|
WO2006078645A2
(en)
|
2005-01-19 |
2006-07-27 |
Neose Technologies, Inc. |
Heterologous polypeptide expression using low multiplicity of infection of viruses
|
EP1866427A4
(de)
|
2005-03-30 |
2010-09-01 |
Novo Nordisk As |
Herstellungsverfahren zur produktion von in insektenzelllinien entstandenen peptiden
|
WO2006121569A2
(en)
|
2005-04-08 |
2006-11-16 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
EP2975135A1
(de)
|
2005-05-25 |
2016-01-20 |
Novo Nordisk A/S |
Glykopegylierter Faktor IX
|
EP1888098A2
(de)
|
2005-05-25 |
2008-02-20 |
Neose Technologies, Inc. |
Glykopegylierte erythropoetin-formulierungen
|
US8633300B2
(en)
|
2005-06-17 |
2014-01-21 |
Novo Nordisk Healthcare Ag |
Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
MX2008002395A
(es)
|
2005-08-19 |
2008-03-18 |
Neose Technologies Inc |
Factor vii y factor viia glicopegilados.
|
WO2007031559A2
(en)
*
|
2005-09-14 |
2007-03-22 |
Novo Nordisk Health Care Ag |
Human coagulation factor vii polypeptides
|
US20090048440A1
(en)
*
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
RU2008145084A
(ru)
|
2006-05-24 |
2010-06-27 |
Ново Нордиск Хелс Кеа Аг (Ch) |
Аналоги фактора ix, имеющие пролонгированное время полужизни in vivo
|
EP2049144B8
(de)
|
2006-07-21 |
2015-02-18 |
ratiopharm GmbH |
Glycosylierung von peptiden über o-verbundene glycosylierungssequenzen
|
ITMI20061624A1
(it)
*
|
2006-08-11 |
2008-02-12 |
Bioker Srl |
Mono-coniugati sito-specifici di g-csf
|
US20100056428A1
(en)
*
|
2006-09-01 |
2010-03-04 |
Novo Nordisk Health Care Ag |
Modified proteins
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
WO2008060780A2
(en)
*
|
2006-10-04 |
2008-05-22 |
Novo Nordisk A/S |
Glycerol linked pegylated sugars and glycopeptides
|
US20080207487A1
(en)
|
2006-11-02 |
2008-08-28 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
PL2144923T3
(pl)
*
|
2007-04-03 |
2013-12-31 |
Biogenerix Ag |
Sposoby leczenia z użyciem glikopegilowanego G-CSF
|
US20090053167A1
(en)
*
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
WO2008151258A2
(en)
|
2007-06-04 |
2008-12-11 |
Neose Technologies, Inc. |
O-linked glycosylation using n-acetylglucosaminyl transferases
|
US9493499B2
(en)
|
2007-06-12 |
2016-11-15 |
Novo Nordisk A/S |
Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
|
FR2918288B1
(fr)
*
|
2007-07-03 |
2009-08-28 |
Zedel Soc Par Actions Simplifi |
Dispositif bloqueur de remontee sur corde double
|
US8207112B2
(en)
*
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|